We are live on ! Find out more
PCM

Pathway Capital Management Portfolio holdings

AUM $23.9M
1-Year Est. Return 81.94%
This Fund
S&P 500
This Quarter Est. Return
+19.1%
1 Year Est. Return
+81.94%
3 Year Est. Return
+629.07%
5 Year Est. Return
+429.81%
10 Year Est. Return
–
AUM
$56M
AUM Growth
+$24.8M
Cap. Flow
+$22.7M
Cap. Flow %
40.5%
Top 10 Hldgs %
100%
Holding
7
New
4
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
DAWN
Day One Biopharmaceuticals
DAWN
+$12.2M
2
ACLX
Arcellx
ACLX
+$4.34M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$3.4M
4
TDG icon
TransDigm Group
TDG
+$2.67M
5
FLYW icon
Flywire
FLYW
+$1.01M

Top Sells

Rank Stock Value
1
DUOL icon
Duolingo
DUOL
+$880K

Sector Composition

Rank Sector Weight
1 Healthcare 55.25%
2 Technology 39.66%
3 Industrials 5.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAWN
1
DELISTED
Day One Biopharmaceuticals
DAWN
$21.4M 38.24%
995,686
+592,559
+147% +$12.2M
TOST icon
2
Toast
TOST
$20.1B
$21.1M 37.61%
1,168,871
– –
ACLX
3
DELISTED
Arcellx
ACLX
$5.86M 10.46%
+189,120
New +$4.34M
AVEO
4
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$3.67M 6.55%
+245,606
New +$3.4M
TDG icon
5
TransDigm Group
TDG
$69.8B
$2.85M 5.09%
+4,530
New +$2.67M
FLYW icon
6
Flywire
FLYW
$2.21B
$1.15M 2.05%
+46,960
New +$1.01M
DUOL icon
7
Duolingo
DUOL
$5.74B
– –
-9,236
Closed -$880K

Similar funds

BH
Broadfin Holdings Melville, New York $23.5M AUM
BCM
BCK Capital Management Stamford, Connecticut $23M AUM 32.69% 1-Year Est. Return
SA
Strategic Advocates Logan, Utah $22.6M AUM 26.98% 1-Year Est. Return
CG
Covalis (Gibraltar) Midtown, Gibraltar $22.5M AUM 9.5% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return
BAM
BTS Asset Management Lincoln, Massachusetts $25.9M AUM 2.16% 1-Year Est. Return
IW
Imprint Wealth Mount Pleasant, South Carolina $21.9M AUM
SPC
Stone Point Capital Greenwich, Connecticut $21.9M AUM 47.18% 1-Year Est. Return

Pathway Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Pathway Capital Management held 7 positions worth $56M, up 80% from $31.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Pathway Capital Management deployed $22.7M of net new capital in Q4 2022, opening 4 new positions and adding to 1 existing holding. Its largest new stake was Arcellx: 189,120 shares worth $5.86M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the most notable exit was Duolingo, an estimated $880K sold.

  • Pathway Capital Management's largest Q4 2022 buy was Arcellx: 189,120 shares worth $5.86M.
  • Pathway Capital Management added most to Day One Biopharmaceuticals in Q4 2022, an estimated $12.2M increase.
  • Pathway Capital Management fully exited Duolingo in Q4 2022, selling an estimated $880K.
  • Pathway Capital Management's ten largest holdings make up 100% of its $56M portfolio in Q4 2022.
  • Pathway Capital Management opened 4 new positions and closed 1 in Q4 2022.
  • Pathway Capital Management's portfolio value rose 80% quarter-over-quarter to $56M.

Based on Pathway Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.